UK markets closed

Novozymes A/S (0Q4U.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
340.95-0.70 (-0.20%)
At close: 06:12PM GMT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
17,553,000
17,553,000
14,951,000
14,012,000
14,374,000
Cost of revenue
7,976,000
7,976,000
6,328,000
6,159,000
6,420,000
Gross profit
9,577,000
9,577,000
8,623,000
7,853,000
7,954,000
Operating expenses
Research development
2,001,000
2,001,000
2,009,000
1,937,000
1,966,000
Selling general and administrative
3,223,000
3,223,000
2,795,000
2,320,000
2,469,000
Total operating expenses
5,149,000
5,149,000
4,738,000
4,243,000
4,409,000
Operating income or loss
4,428,000
4,428,000
3,885,000
3,610,000
3,545,000
Interest expense
102,000
102,000
102,000
63,000
86,000
Income before tax
4,556,000
4,556,000
3,924,000
3,521,000
3,799,000
Income tax expense
870,000
870,000
779,000
695,000
644,000
Income from continuing operations
3,686,000
3,686,000
3,145,000
2,826,000
3,155,000
Net income
3,676,000
3,676,000
3,146,000
2,825,000
3,154,000
Net income available to common shareholders
3,676,000
3,676,000
3,146,000
2,825,000
3,154,000
Basic EPS
-
-
11.32
10.07
11.06
Diluted EPS
-
-
11.23
10.02
11.01
Basic average shares
-
-
277,919
280,428
285,110
Diluted average shares
-
-
280,228
282,023
286,551
EBITDA
-
6,115,000
5,442,000
4,850,000
5,067,000